# Cost Considerations in Penile Implant Surgery from a Global Perspective

## TL;DR

This paper reviews how rising costs and limited insurance coverage make penile implant surgery less accessible globally, especially in low- and middle-income countries.

## Contribution

The paper highlights cost-saving strategies like ambulatory surgery and low-cost devices to improve access to penile implants for erectile dysfunction.

## Key findings

- Ambulatory surgical centers in the U.S. may reduce penile implant costs.
- Low-cost devices like the Shah Malleable Prosthesis improve accessibility in LMICs.
- Insurance expansion and policy reform are needed to make implants more affordable globally.

## Abstract

This review evaluates global trends, economic considerations, and recent innovations in penile prosthesis surgery for erectile dysfunction (ED). It aims to examine rising procedural costs, disparities in accessibility, and strategies to enhance affordability particularly in low- and middle-income countries (LMICs).

Despite its cost-effectiveness and high patient satisfaction, penile prosthesis surgery remains underutilized due to increasing costs and inconsistent insurance coverage. In the U.S., a shift toward ambulatory surgical centers may help reduce procedural costs. Low-cost devices like the Shah Malleable Prosthesis have improved accessibility in LMICs but face limited global adoption due to regulatory and evidence gaps. Broader health system reforms and novel tools such as predictive digital models may further mitigate economic barriers.

Penile prosthesis implantation is a durable and effective treatment for ED but remains financially inaccessible to many patients worldwide. Reducing costs through outpatient surgery, insurance expansion, and validated low-cost devices can improve global access. Future progress requires coordinated policy reform and investment in scalable, equitable care pathways.